CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
ESGCX
Price
$20.10
Change
-$0.15 (-0.74%)
Updated
Jul 13 closing price
Net Assets
658.86M
Interact to see
Advertisement

CNPAX vs ESGCX

CNPAX vs ESGCX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. ESGCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and ESGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. ESGCX (659M). CNPAX pays higher dividends than ESGCX: CNPAX (0.95) vs ESGCX (0.00). CNPAX was incepted earlier than ESGCX: CNPAX (24 years) vs ESGCX (10 years). ESGCX (2.01) is less costly to investors than CNPAX (0.74). CNPAX is a more actively managed with annual turnover of: 23.00 vs. ESGCX (21.00). CNPAX has a lower initial minimum investment than ESGCX: CNPAX (250) vs ESGCX (2500). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. ESGCX (1.82). CNPAX return over 5 years is better than : 13.82 vs. ESGCX (-3.55).
CNPAXESGCXCNPAX / ESGCX
Total Expense Ratio0.741.9538%
Annual Report Gross Expense Ratio0.742.0137%
Fund Existence24 years10 years-
Gain YTD5.325-1.374-388%
Front Load4%N/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets170B659M25,797%
Annual Yield % from dividends0.950.00-
Returns for 1 year7.371.82404%
Returns for 3 years34.1720.04171%
Returns for 5 years13.82-3.55-389%
Returns for 10 years115.9198.63118%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6